SCHEMBL5648423

SCHEMBL5648423

CCCC(CCC)S(=O)(=O)C[C@](N)(C(N)=O)C(=O)c1ccc(OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
MMP1 P03956 3/20 0.41
MMP13 P45452 2/20 0.41
CA2 P00918 4/20 0.40
CA1 P00915 3/20 0.40
PARP10 Q53GL7 2/20 0.40
PARP1 P09874 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
PARP4 Q9UKK3 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MMP2 P08253 2/20 0.37
MMP3 P08254 2/20 0.37
ALDH1A1 P00352 3/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648426 1.00 TAS1R3 (0.43) TAS1R3TAS1R1MMP1MMP13CA2
Hydrochloric Acid SCHEMBL4664377 0.99 TAS1R3 (0.42) TAS1R3TAS1R1MMP1MMP13CA2
Hydrochloric Acid SCHEMBL4664379 0.99 TAS1R3 (0.42) TAS1R3TAS1R1MMP1MMP13CA2
SCHEMBL5648267 0.86 CA2 (0.36) CA2SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL5648261 0.86 CA2 (0.36) CA2SLC6A2SLC6A4SLC6A3ALDH1A1
Hydrochloric Acid SCHEMBL4664308 0.85 CA2 (0.35) CA2SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL5651161 0.83 SLC6A4 (0.41) TAS1R3TAS1R1SLC6A4POLBMAPK1
SCHEMBL5651164 0.83 SLC6A4 (0.41) TAS1R3TAS1R1SLC6A4POLBMAPK1
Hydrochloric Acid SCHEMBL4773400 0.82 SLC6A4 (0.40) TAS1R3TAS1R1SLC6A4POLBMAPK1
Hydrochloric Acid SCHEMBL4773407 0.82 SLC6A4 (0.40) TAS1R3TAS1R1SLC6A4POLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144897-B2 Hydroxy alkyl amines Elan Oharmaceuticals, Inc. (US) 2006-12-05 US claimed
US-20030166717-A1 Hydroxy alkyl amines FRESKOS JOHN (US) 2003-09-04 US claimed
US-20070299263-A1 Hydroxy Alkyl Amines Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company 2007-12-27 US disclosed
US-7144897-B2 Hydroxy alkyl amines Elan Oharmaceuticals, Inc. (US) 2006-12-05 US disclosed
US-20030166717-A1 Hydroxy alkyl amines FRESKOS JOHN (US) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166717-A1 Hydroxy alkyl amines PSEN1, MAOA, PSEN2 TAS1R3 4174/4885TAS1R1 3556/4885MMP1 4190/4885
US-20070299263-A1 Hydroxy Alkyl Amines MAOA, PSEN2, PSEN1 TAS1R3 4486/4885TAS1R1 4378/4885MMP1 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.